Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

KYTX Clue Score44

United States Fiscal year ends December CIK 0001994702 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$47.39M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$292.78K

$0.00 on a plan · $292.78K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

+$47.10M

+$47.39M against sales at will